ERBB2 and triple-negative breast carcinoma: Hormone-negative breast cancers, which are associated with the poorest prognosis, are subdivided into two groups depending on HER2 overexpression: HER2-positive (HER2), characterized by HER2 amplification, and basal-like (or triple-negative breast cancer, TNBC) [1].